|
Index of reports
> Cases resulting in a serious event (381)
> Cases with Interstitial Lung Disease (21)
Below is the selection of adverse event reports related to Micardis (Telmisartan) that includes cases resulting in a serious event where reactions include interstitial lung disease.
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-06-20
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-06-18
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Adverse event in female receiving Micardis (Telmisartan)
Reported by a individual with unspecified qualification from Japan on 2007-06-15
Patient: female
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Daonil; Basen; Actos; Prednisolone; Gaster D; Gaslon N (Irsogladine Maleate); Lipitor; Amlodin; Theolong; Hokunalin:tape (Ulobuterol); Dextromethorphan Hydrobromide
Adverse event in female receiving Micardis (Telmisartan)
Reported by a individual with unspecified qualification from Japan on 2007-06-13
Patient: female
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Daonil; Basen; Actos; Prednisolone; Gaster D; Gaslon N (Irsogladine Maleate); Lipitor; Amlodin; Theolong; Hokunalin:tape (Ulobuterol); Dextromethorphan Hydrobromide
Adverse event in female receiving Micardis (Telmisartan)
Reported by a individual with unspecified qualification from Japan on 2007-06-11
Patient: female
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Daonil; Basen; Actos; Prednisolone; Gaster D; Gaslon N (Irsogladine Maleate); Lipitor; Amlodin; Theolong; Hokunalin:tape (Ulobuterol); Dextromethorphan Hydrobromide
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-05-23
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-01-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Other drugs received by patient: Flomox; Kirpres; Mucosolvan; Medicon
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-04-26
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-01-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Other drugs received by patient: Flomox; Kirpres; Mucosolvan; Medicon
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-04-13
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Norvasc; Tenormin
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-03-28
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Adverse event in male receiving Micardis (Telmisartan)
Reported by a pharmacist from Japan on 2007-03-27
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-03-01
Patient: male, weighing 68.5 kg (150.7 pounds)
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Urinorm; Lipovas; Tagamet; SLO-BID; Meptin; Uralyt; Aplace; TS-1
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-03-01
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-02-23
Patient: male, weighing 68.5 kg (150.7 pounds)
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Urinorm; Lipovas; Tagamet; SLO-BID; Meptin; Uralyt; Aplace; TS-1
Adverse event in male receiving Micardis (Telmisartan)
Reported by a pharmacist from Japan on 2007-02-22
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Micardis (Telmisartan)
Reported by a pharmacist from Japan on 2007-02-22
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-02-20
Patient: male, weighing 69.0 kg (151.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Urinorm; Lipovas; Tagamet; SLO-BID; Meptin; Uralyt; Aplace; TS-1
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-02-12
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Adverse event in male receiving Micardis (Telmisartan)
Reported by a pharmacist from Japan on 2007-02-08
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-01-30
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-02
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-02
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-02
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-01-23
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Suspect drug(s):
Atenolol
Administration route: Oral
Micardis
Administration route: Oral
Norvasc
Administration route: Oral
Adverse event in male receiving Micardis (Telmisartan)
Reported by a pharmacist from Japan on 2007-01-19
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Suspect drug(s):
Micardis
Administration route: Oral
Norvasc
Administration route: Oral
Tenormin
Administration route: Oral
|
